Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

THALOMID 50 MG

THALIDOMIDE : 50 MG · DIN 02355191 · BRISTOL-MYERS SQUIBB CANADA

Health Canada status: MARKETED

What is THALOMID?

THALOMID 50 MG contains THALIDOMIDE : 50 MG. It is listed in the Health Canada Drug Product Database under DIN 02355191, held by BRISTOL-MYERS SQUIBB CANADA, supplied as CAPSULE for ORAL administration. Health Canada currently lists it as marketed, status dated 12-Jun-2024. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

What is THALOMID used for?

In combination with melphalan and prednisone (MPT) for the treatment of patients with previously untreated multiple myeloma who are 65 years of age or older.

Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.

Product details and regulatory record

DIN02355191
Brand nameTHALOMID
Generic / active ingredientTHALIDOMIDE : 50 MG
ManufacturerBRISTOL-MYERS SQUIBB CANADA
Strength50 MG
Dosage formCAPSULE
Route of administrationORAL
SchedulePrescription
ATC codeL04AX02 THALIDOMIDE
AHFS class92:20.00
BiosimilarNo
Health Canada statusMARKETED
Status date12-Jun-2024
Original market date2010-11-01 00:00:00

How is it administered?

Oral, single dose at bedtime. Previously untreated MM: 200 mg/day (≤75 years) or 100 mg/day (>75 years) in combination with melphalan and prednisone for up to 12 cycles (6 weeks each).

Included because it drives pack selection and wastage. Consult the monograph.

How is it stored and handled?

Keep in the blister package until it is time to take them. (Specific temperature range not provided in text).

How is it supplied?

Blister packages. Available strengths: 50 mg (white opaque) and 100 mg (tan opaque).

Contraindications

Pregnant women; females of child-bearing potential (unless RevAid conditions met); hypersensitivity to thalidomide, lenalidomide, or pomalidomide; breastfeeding women; certain male patients.

Warnings and precautions

Human birth defects; Peripheral Neuropathy; Thromboembolic events (VTE/ATE); Hepatotoxicity; Anaphylaxis; Serious infections; HBV reactivation; PML. Available only via RevAid program.

What can be used instead?

Other Canadian products sharing ATC code L04AX02 THALIDOMIDE. 2 of 4 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
THALOMID100 MGCAPSULEBRISTOL-MYERS SQUIBB CANADAMARKETEDDIN 02355205
THALOMID150 MGCAPSULECELGENE INCCANCELLED PRE MARKETDIN 02355213
THALOMID200 MGCAPSULEBRISTOL-MYERS SQUIBB CANADACANCELLED POST MARKETDIN 02355221

Who else supplies THALIDOMIDE worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. THALIDOMIDE appears in 10 registered pack listings across 7 markets, published on 6 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for THALOMID

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for THALOMID

Health Canada Drug Product Database (DPD), DIN 02355191. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.